Delta Sleep-Inducing Peptide (DSIP) vs Vilon
Research Verdict
Neither compound has a universal evidence advantage. Research distinction: Sleep neurophysiology research where historical human EEG data exists vs. Khavinson dipeptide bioregulator research focused on immune modulation, accepting extremely limited .
Quick Answers
Which is better, Delta Sleep-Inducing Peptide (DSIP) or Vilon?
Neither compound has a universal evidence advantage. Research distinction: Sleep neurophysiology research where historical human EEG data exists vs. Khavinson dipeptide bioregulator research focused on immune modulation, accepting extremely limited .
What is the key difference between Delta Sleep-Inducing Peptide (DSIP) and Vilon?
DSIP is a nine-amino-acid peptide with documented neurophysiological effects; vilon is a dipeptide with a putative immunomodulatory role - DSIP has vastly more scientific characterization.
Evidence Comparison
DSIP: discovered 1970s, uncontrolled human studies, substantial animal neurophysiology data. Vilon (Lys-Glu): Khavinson dipeptide with minimal published data, single research group. DSIP has meaningfully more published evidence.
Evidence Context Favoring Delta Sleep-Inducing Peptide (DSIP)
Sleep neurophysiology research where historical human EEG data exists.
Evidence Context Favoring Vilon
Khavinson dipeptide bioregulator research focused on immune modulation, accepting extremely limited evidence.
Side-by-Side Snapshot
| Evidence grade | Delta Sleep-Inducing Peptide (DSIP): Level C Vilon: Level D |
|---|---|
| Research status | Delta Sleep-Inducing Peptide (DSIP): Preclinical Vilon: Early Research |
| Primary category | Delta Sleep-Inducing Peptide (DSIP): Anti-Aging & Longevity Vilon: Anti-Aging & Longevity |
| Cited studies | Delta Sleep-Inducing Peptide (DSIP): 2 Vilon: 2 |